160 related articles for article (PubMed ID: 17241926)
21. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.
Qiao J; Fu J; Fang T; Huang Y; Mi H; Yang N; Chen C; Xu K; Zeng L
Exp Mol Pathol; 2015 Feb; 98(1):73-8. PubMed ID: 25533545
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Park SH; Lee MH; Lee H; Kim HS; Kim K; Kim WS; Jung CW; Im YH; Yoon SS; Kang WK; Park K; Park CH; Kim SW
Bone Marrow Transplant; 2002 Jan; 29(2):137-43. PubMed ID: 11850708
[TBL] [Abstract][Full Text] [Related]
23. Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
Nassereddine S; Alsubait S; Tabbara I
Anticancer Res; 2018 May; 38(5):2597-2605. PubMed ID: 29715079
[TBL] [Abstract][Full Text] [Related]
24. Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation.
Cowan J; Cameron DW; Knoll G; Tay J
BMJ Open; 2015 Aug; 5(8):e008316. PubMed ID: 26297369
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Society for Blood and Marrow Transplantation (EBMT).
Chung H; Im SA; Kim SK
Pediatr Hematol Oncol; 2020 May; 37(4):275-287. PubMed ID: 32131664
[TBL] [Abstract][Full Text] [Related]
26. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature.
Hopps SA; Borders EB; Hagemann TM
J Oncol Pharm Pract; 2016 Jun; 22(3):496-510. PubMed ID: 26126501
[TBL] [Abstract][Full Text] [Related]
28. Ursodeoxycholic acid for primary biliary cirrhosis.
Gong Y; Huang ZB; Christensen E; Gluud C
Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of hepatic sinusoidal obstructive syndrome after hematopoietic stem cell transplantation in a child using recombinant thrombomodulin.
Yamamoto S; Yagawa A; Toyama D; Akiyama K; Hayashi M; Mabuchi M; Shimizu T; Ikeda H; Isoyama K
Acta Haematol; 2013; 129(1):62-4. PubMed ID: 23147560
[No Abstract] [Full Text] [Related]
30. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Liao C
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
[TBL] [Abstract][Full Text] [Related]
31. A murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation.
Zeng L; An L; Fang T; Pan B; Sun H; Chen C; Cao J; Li Z; Xu K
Cell Biochem Biophys; 2013; 67(3):939-48. PubMed ID: 23579582
[TBL] [Abstract][Full Text] [Related]
32. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
33. Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group.
Bonifazi F; Sica S; Angeletti A; Marktel S; Prete A; Iori AP; Olivari D; Rossetti G; Bertaina A; Botti S; Busca A; Carella AM; Cerretti R; Gargiulo G; Grassi A; Gualandi F; Irrera G; Milone G; Risitano AM; Santarone S; Vassallo E; Zecca M; Ciceri F; Pomponio G
Transplantation; 2021 Apr; 105(4):686-694. PubMed ID: 33273315
[TBL] [Abstract][Full Text] [Related]
34. Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.
Sakaguchi H; Watanabe N; Muramatsu H; Doisaki S; Yoshida N; Matsumoto K; Kato K
Pediatr Blood Cancer; 2010 Dec; 55(6):1118-25. PubMed ID: 20589662
[TBL] [Abstract][Full Text] [Related]
35. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
Song JS; Seo JJ; Moon HN; Ghim T; Im HJ
J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
[TBL] [Abstract][Full Text] [Related]
37. Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
Battipaglia G; Labopin M; Candoni A; Fanin R; El Cheikh J; Blaise D; Michallet M; Ruggeri A; Contentin N; Ribera JM; Stadler M; Sierra J; von dem Borne PA; Bloor A; Socié G; Nagler A; Mohty M
Bone Marrow Transplant; 2017 Apr; 52(4):592-599. PubMed ID: 28092357
[TBL] [Abstract][Full Text] [Related]
38. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation.
Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK
Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499
[TBL] [Abstract][Full Text] [Related]
39. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.
Deng YL; Xiong XZ; Cheng NS
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):464-73. PubMed ID: 25308356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
